Bayer, Monsanto and Max Planck Society cut deal
Monsanto Co., Bayer CropScience and the Max Planck Society on Feb. 4 said they have resolved a long-standing patent dispute by agreeing to cross-license each other for a type of technology that allows scientists to transfer DNA into plant cells. Monsanto, a leader in the development of genetically modified plants, uses the process to make cotton plants resistant to pests, while Bayer has been using the technology to make herbicide-resistant canola and cotton seed products.
We have discussed elsewhere some issues with the success of Bt-cotton in India.
In February 2004, Monsanto announced a similar settlement with Swiss agrochemicals maker Syngenta. The two agreed to swap licenses relating to transgenic broad leaf crops to end a patent-interference case with the U.S. Patent and Trademark Office.
The various settlements remind one of the settlement between Fairchild and Texas Instruments over the integrated circuit (IC).